Anebulo Pharmaceuticals, Inc.
ANEB
Revenue
0.00
0.000.00%
-Assets
15.84M
▲13.37M▲541.88%
3 Months ChangeLiabilities
878.80k
▲309.57k▲54.39%
3 Months ChangeFree Cash Flow
0.00
0.000.00%
-Revenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-17
Form 8-K
ID: 0001493152-24-041362
2024-09-25
Form 8-K
ID: 0001493152-24-038112
2024-07-22
Form 8-K
ID: 0001493152-24-028629
2024-06-17
Form 8-K
ID: 0001493152-24-024096
2024-05-15
Form 10-Q
ID: 0001493152-24-019922
2024-05-15
Form 8-K
ID: 0001493152-24-019877
2024-02-13
Form 10-Q
ID: 0001493152-24-006103
2024-02-13
Form 8-K
ID: 0001493152-24-006087
2023-11-21
Form 8-K
ID: 0001493152-23-042292
2023-11-14
Form 10-Q
ID: 0001493152-23-041171